Endocannabinoid System Research: Cannabis Use in Pregnancy
Maternal cannabis use in pregnancy is linked to a modestly elevated risk of autism spectrum disorder and ADHD in children. This association is supported by pooled data from multiple observational studies. Current evidence advises caution due to potential…
Cannabis Derivatives for Autism: Clinical Evidence & Research
Several randomized clinical trials have examined cannabis derivatives autism spectrum disorder symptoms. Findings suggest potential benefits for behavioral challenges and social functioning. The evidence base remains limited, so no definitive clinical…
Endocannabinoid System & Teen Anxiety: Clinical Evidence
Internalising symptoms adolescent cannabis use is linked to increased risk of initiation and escalation among teens. This clinical evidence highlights the importance of screening for anxiety and depression in adolescents. Understanding these risks can…
Understanding the Risk of Psychiatric Disorders from Adolescent Cannabis Use
Adolescent cannabis psychiatric disorders risk includes increased chances of psychotic, bipolar, depressive, and anxiety disorders. This risk is supported by large population-level clinical data. Understanding this risk helps guide adolescent mental…
Endocannabinoid System & Trauma Sleep Research Insights
Pre-trauma insomnia and substance use are linked in trauma survivors, increasing risk for problematic alcohol and cannabis use. Early posttraumatic stress symptoms partially mediate this relationship. Addressing sleep disturbances may reduce substance…
Trauma-Focused Treatment and Cannabis Use in PTSD Care
Trauma-focused treatment PTSD cannabis use remains effective even with co-occurring substance use disorders. Cannabis use does not reduce the benefits of trauma-focused psychotherapy. This insight supports maintaining evidence-based PTSD care protocols.
Cannabinoids for Chronic Pain: Evidence and Clinical Insights
Cannabinoid efficacy chronic pain clinical evidence shows modest but consistent pain reduction in controlled trials. Clinical outcomes vary by product formulation and patient factors. This evidence supports cautious, individualized use in pain management.
Endocannabinoid System & PTSD: Cannabis Meta-Analysis
This meta-analysis examines cannabis use trauma-focused treatment in individuals with PTSD and co-occurring substance use disorders. Findings show trauma-focused therapies remain effective despite cannabis use. Cannabis use trauma-focused treatment does…
Cannabinoids for Children: Clinical Evidence Reviewed
Current cannabinoids pediatric safety evidence spans 276 studies covering plant-derived and pharmaceutical formulations for children under 18. This clinical review synthesizes safety and reported benefits from interventional trials and observational…
VER-01 Cannabis Extract: Phase 3 Trial for Chronic Back Pain
The VER-01 cannabis extract clinical trial evaluated 820 adults with chronic low back pain in a rigorous phase 3 study. Results demonstrated significant pain reduction and a favorable safety profile. This trial adds important clinical evidence for…